• Go to the menu
  • Go to content
Bioregate Logo RFI
Rechercher
My accountLogin
  • fr
  • en
Contact Donate
Menu
  • Bioregate
    • Missions
    • Consortium
    • Organization
    • Operational team
    • Regional skills overview
  • Skills
    • Players Network
      • Research laboratories
      • Technology platforms
      • Clinical Innovation
      • Companies
    • Innovation supports
  • Projects
    • Research projects
    • Clinical trials
    • R&D projects
    • Publications
  • Education & Training
  • Partnerships
  • Agenda & News
  • Calls for projects
  • Bioregate Forum
    • 2016 Edition
    • 2018 Edition
  1. Home
  2. Innovation

1 December 2021

Save the Date! The next Bioregate Forum will take place from 21st to 23rd September in Brussels!

Découvrez le programme de la journée ! SAVE THE DATE After 2 successful editions, we

Repair medicine
Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Education
Innovation
Read more

16 January 2020

Call for proposals “Hosting of foreign post-doctoral students”

Bioregate is launching its call for proposals “Hosting of foreign post-doctoral students” dedicated to members

Repair medicine
Regenerative Medicine
Research
Education
Innovation
Read more

15 January 2019

Goliver Therapeutics

General activities   Goliver Therapeutics is a biotechnology company, spin-off from the Inserm and Nantes

Regenerative Medicine
Research
Innovation
Read more

11 January 2019

GREAT SUCCESS OF THE 2ND EDITION OF THE BIOREGATE FORUM – 12-14 DECEMBER 2018, NANTES, FRANCE

In December in Nantes, an International Forum dedicated to regenerative medicine was held, bringing together

Repair medicine
Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Innovation
Read more

13 November 2018

Health of the future: Nantes researchers develop tomorrow’s therapies at European level

Major discoveries in molecular and cellular biology have made it possible in recent years to

Regenerative Medicine
Research
Innovation
Read more

20 September 2018

GenOA

Osteoarthritis (OA) is the most common degenerative musculoskeletal disease. It affects approximately 10 million people

Regenerative Medicine
Research
Innovation
Read more

1 2 3 … 10 Next page
Back to top
  • Logo RFI
  • Bioregate
  • Contact
  • Terms and conditions
  • Site map

Led by

  • Université - Nantes

Funded by

In partnership with

  • logo-lemans-universite
  • Atlanpole-Biotherapies
© 2023 Bioregate All rights reserved.